Left Ventricular Thrombus Clinical Trial
Official title:
Apixaban in Patients With Left Ventricular Thrombus Post Myocardial Infarction; A Randomized Clinical Trial
Open label randomized controlled clinical trial to evaluate the efficacy and safety of apixaban versus warfarin in treating left ventricular thrombus in patients with acute or recent myocardial infarction (MI).
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05077683 -
Direct Oral Anticoagulants for Prevention of lEft ventRIcular Thrombus After Anterior Acute Myocardial InFarction - APERITIF
|
Phase 3 | |
Recruiting |
NCT04970576 -
Rivaroxaban in Left Ventricular Thrombus
|
Phase 4 | |
Not yet recruiting |
NCT03415386 -
Optimized Antithrombotic Therapy of Acute Myocardial Infarction With Left Ventricular Mural Thrombus
|
Phase 4 | |
Completed |
NCT04871126 -
Predictive Value of Inflammatory Indexes and CHA2DS2-VASc Score for LVT in ANT-MI With Left Ventricular Dysfunction
|
||
Recruiting |
NCT03764241 -
Treatment of Post-STEMI Left Ventricular Thrombus With Optimized Anticoagulant
|
Phase 3 | |
Recruiting |
NCT04829825 -
The "MyoThrombus" Study
|
||
Not yet recruiting |
NCT03786757 -
Prevention of Post-STEMI Left Ventricular Thrombus With Optimized Anticoagulant (EARLYmyo-LVT Ⅱ)
|
Phase 3 |